Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors

NCT07108140 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

TERMINATED

Status

5

Enrollment

INDUSTRY

Sponsor class

Stopped Portfolio prioritization

Conditions

Solid Tumor

Interventions

BIOLOGICAL: Anti ALPP CAR-T cells treatment

Sponsor

TCRCure Biopharma Ltd.

Collaborators

[object Object]